April 23, 2025 9:45–10:05 AM
Strategy 1
Moleculera Biosciences is pioneering the diagnosis, treatment, and monitoring of immune-related neuropsychiatric, cardiovascular, Long-COVID, and neurodegenerative disorders. The complexity of immune-mediated chronic conditions has placed an enormous burden on the healthcare system, which is at the core of the future of human health. We enable clinicians with technologies needed to accurately diagnose, treat, and monitor patients suffering from certain chronic debilitating disorders to experience remarkable recoveries.
Sponsors
